Will Marijuana for Sick Kids Get Government to Rethink Weed?

For years, opponents of legalizing medical marijuana have built their case on the most powerful of political maxims: Think about the children. But today it’s the suffering of children that might eventually compel the federal government to relax its stance.

Thousands of kids across the United States are afflicted with Dravet Syndrome and Lennox-Gastaut Syndrome, rare forms of childhood-onset epilepsy that can cause dozens, even hundreds, of severe seizures each day. Conventional drugs have been ineffective.

Last year, however, the FDA approved a clinical trial of Epidiolex, a drug made from cannabidiol (CBD)—one of 85 active chemical compounds, called cannabinoids, in marijuana. The initial findings were promising. After 12 weeks of treatment, 54 percent of patients experienced fewer seizures and 9 percent saw their seizures cease. The trial has already moved to a double-blind, placebo-controlled study. (Read about

...
Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.


URL: 
http://news.nationalgeographic.com/2015/05/150515-medical-marijuana-federal-policy-research/